Buzz...no words of wisdom from me. I realize there are differing opinions on this issue, but I believe DMRJ's sells in volume at the $1.20 to $1.40 range, effectively capping any rally that could spur additional investor interest, and so until that overhang is eliminated, one way or the other, we just have no way of knowing how high Implant could go.
In making any sort of value determination, I think its important to remember Implant is in the ETD space, not EDS. Management has always said their goal was to capture one-third of a $300 million a year market, and I take them at their word on that. There are a lot of soothsayers and prognosticators who post mysterious hints that "those in the know" realize the company's potential is infinitely larger. Well, I'm not in the know, and so I have to go with the guidance management is willing to provide in a public forum rather than one-on-one conversations.